Patents by Inventor Vassilia Theodorou

Vassilia Theodorou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • strains for treating and preventing gastrointestinal pain
    Patent number: 11717543
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: August 8, 2023
    Assignees: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, ECOLE D'INGENIEURS DE PURPAN
    Inventors: Philippe Langella, Sylvie Miquel, Rebeca Martin Rosique, Luis Bermudez Humaran, Muriel Thomas, Harry Sokol, Frédéric Carvalho, Vassilia Theodorou
  • LACTOCOCCUS LACTIS STRAINS FOR THE PREVENTION AND/OR THE TREATMENT OF VISCERAL PAIN
    Publication number: 20220152126
    Abstract: A Lactococcus lactis strain or a cell fraction thereof for use in the prevention and/or treatment of visceral pain is provided.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 19, 2022
    Inventors: Muriel COCAIGN-BOUSQUET, Hélène EUTAMENE, Muriel MERCIER BONIN, Vassilia THEODOROU, Valérie LAROUTE, Marie-Line DAVERAN-MINGOT
  • FAECALIBACTERIUM PRAUSNITZII STRAINS FOR TREATING AND PREVENTING GASTROINTESTINAL PAIN
    Publication number: 20200316138
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Philippe LANGELLA, Sylvie MIQUEL, Rebeca MARTIN ROSIQUE, Luis BERMUDEZ HUMARAN, Muriel THOMAS, Harry SOKOL, Frédéric CARVALHO, Vassilia THEODOROU
  • FAECALIBACTERIUM PRAUSNITZII STRAINS FOR TREATING AND PREVENTING GASTROINTESTINAL PAIN
    Publication number: 20190381115
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Application
    Filed: November 13, 2015
    Publication date: December 19, 2019
    Applicants: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (APHP), ECOLE D'INGENIEURS DE PURPAN
    Inventors: Philippe LANGELLA, Sylvie MIQUEL, Rebeca MARTIN ROSIQUE, Luis BERMUDEZ HUMARAN, Muriel THOMAS, Harry SOKOL, Frédéric CARVALHO, Vassilia THEODOROU
  • Use of for the prevention or treatment of digestive pathologies
    Patent number: 7628991
    Abstract: The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: December 8, 2009
    Assignee: Institute National de la Recherche Agronomique (INRA)
    Inventors: Jean Fioramonti, Lionel Bueno, Vassilia Theodorou, Florence Lamine
  • Use of for the prevention or treatment of digestive pathologies
    Patent number: 7294337
    Abstract: The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: November 13, 2007
    Assignee: Institut National de la Recherche Agronomique (INRA)
    Inventors: Jean Fioramonti, Lionel Bueno, Vassilia Theodorou, Florence Lamine
  • Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
    Publication number: 20050244389
    Abstract: The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.
    Type: Application
    Filed: March 21, 2003
    Publication date: November 3, 2005
    Inventors: Jean Fioramonti, Lionel Bueno, Vassilia Theodorou, Florence Lamine
  • ?E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine, and its antidiarrhoeal use
    Patent number: 6440997
    Abstract: (−)E-2-(3,4-dichlorocinnamyl)-1-cyclo-propylmethyl-piperidine of formula I: and its pharmaceutically acceptable salts, is useful for treating diarrhea in mammals. Also disclosed are pharmaceutical compositions, processes for preparing compounds of formula (I) and intermediates useful for preparing compounds of formula I.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: August 27, 2002
    Assignee: Warner-Lambert Company
    Inventors: Alain Calvet, Maria Chovet, Svein Dahl, Henry Jacobelli, Vassilia Theodorou, Pierre Riviere
  • (-)E-2-(3,4-DICHLOROCINNAMYL)-1-CYCLOPROPYLMETHYL-PIPERIDINE, AND ITS ANTIDIARRHOEAL USE
    Publication number: 20010008897
    Abstract: (−)E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine of formula (I) and its addition salts with pharmaceutically acceptable acids; their use as antidiarrhoeals in mammals; pharmaceutical compositions intended for treatment of diarrhoeas.
    Type: Application
    Filed: November 10, 1999
    Publication date: July 19, 2001
    Inventors: ALAIN CALVET, MARIA CHOVET, SVEIN DAHL, HENRY JACOBELLI, VASSILIA THEODOROU, PIERRE RIVIERE